NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Avenue Therapeutics Inc (NASDAQ: ATXI)

 
ATXI Technical Analysis
2
As on 21st Jul 2025 ATXI STOCK Price closed @ 0.55 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.42 & Buy for SHORT-TERM with Stoploss of 0.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ATXISTOCK Price

Open 0.43 Change Price %
High 0.55 1 Day 0.17 44.74
Low 0.43 1 Week -0.42 -43.30
Close 0.55 1 Month -0.79 -58.96
Volume 4305 1 Year -0.14 -20.29
52 Week High 6.20 | 52 Week Low 0.09
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
OPEN 3.17 4.28%
INTC 24.56 2.93%
PGEN 2.94 58.92%
NVDA 180.45 -0.86%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PPSI 4.35 39.87%
TLRY 1.03 -12.71%
CODX 0.29 7.41%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
SRAX 0.05 150.00%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.05 -58.33%
MILEW 0.06 -53.85%
 
 
ATXI
Daily Charts
ATXI
Intraday Charts
Whats New @
Bazaartrend
ATXI
Free Analysis
 
ATXI Important Levels Intraday
RESISTANCE0.78
RESISTANCE0.71
RESISTANCE0.66
RESISTANCE0.62
SUPPORT0.48
SUPPORT0.44
SUPPORT0.39
SUPPORT0.32
 
ATXI Forecast August 2025
4th UP Forecast1.4
3rd UP Forecast1.13
2nd UP Forecast0.96
1st UP Forecast0.79
1st DOWN Forecast0.31
2nd DOWN Forecast0.14
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.3
 
ATXI Weekly Forecast
4th UP Forecast0.86
3rd UP Forecast0.76
2nd UP Forecast0.70
1st UP Forecast0.64
1st DOWN Forecast0.46
2nd DOWN Forecast0.40
3rd DOWN Forecast0.34
4th DOWN Forecast0.24
 
ATXI Forecast2025
4th UP Forecast17.7
3rd UP Forecast12.2
2nd UP Forecast8.8
1st UP Forecast5.4
1st DOWN Forecast-4.3
2nd DOWN Forecast-7.7
3rd DOWN Forecast-11.1
4th DOWN Forecast-16.6
 
 
ATXI Other Details
Segment EQ
Market Capital 27036892.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ATXI Address
ATXI
 
ATXI Latest News
 
Your Comments and Response on Avenue Therapeutics Inc
 
ATXI Business Profile
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York. Address: 1140 Avenue of the America, New York, NY, United States, 10036
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service